369 Crystallization of Pharmaceutical and Biological Molecules I

Monday, November 16, 2020: 8:00 AM - 9:00 AM
Separations Division (02) (PreRecorded+)

Description:
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Sponsor:
Crystallization and Evaporation
Co-Sponsor(s):
Food, Pharmaceutical & Bioengineering Division (15), Pharmaceutical Discovery, Development and Manufacturing Forum (26)
Chair:
Marina Tsianou Email: mtsianou@buffalo.edu
Co-Chair:
Haitao Zhang Email: haitao.zhang@sunovion.com


(369a) Enzymatic Reactive Crystallization of Cephalexin Using Immobilized Penicillin G Acylase from E. coli
Patrick R. Harris, Hossein Salami, Matthew A. McDonald, Grant D. Marshall, Ronald W. Rousseau, Martha A. Grover and Andreas S. Bommarius


(369b) Recrystallization Development for Small Molecule API (Active Pharmaceutical Ingredient) Islatravir
Rachel S. Bade, Richard Varsolona, Dirk Stueber, Kevin Sirk, Jacob Heltzel, Athanas Koynov and Eric Margelefsky


(369c) Seeding Strategies for the Selective Crystallisation of Model Proteins
Ian Rosbottom, Xiaoyu Li, Wenqian Chen and Jerry Y. Y. Heng


(369d) Developing a Scalable Templating-Platform for Enhancing Crystallisation of Bio-Active Proteins
Frederik J. Link and Jerry Y. Y. Heng


(369e) Sensor Integrated Continuous Microfluidic Mixer for Protein Screening at Constant Supersaturation
Paria Coliaie, Manish S. Kelkar, Nandkishor K. Nere and Meenesh R. Singh


(369g) Particle Size Control of a Drug Substance through Process Crystallization
Otute Akiti, Tanya Wallace, Matteo Daldosso, Federico Scaravelli, Martina Saccani, Irene Parisini, Francesco Martinelli, Davide Comisso, Wayne Morley and Marina Galvani
See more of this Group/Topical: Separations Division
<< Previous Session | Next Session >>